Literature DB >> 21953216

Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.

Raquel Urtasun1, Aritz Lopategi, Joseph George, Tung-Ming Leung, Yongke Lu, Xiaodong Wang, Xiaodong Ge, Maria Isabel Fiel, Natalia Nieto.   

Abstract

UNLABELLED: A key feature in the pathogenesis of liver fibrosis is fibrillar Collagen-I deposition; yet, mediators that could be key therapeutic targets remain elusive. We hypothesized that osteopontin (OPN), an extracellular matrix (ECM) cytokine expressed in hepatic stellate cells (HSCs), could drive fibrogenesis by modulating the HSC pro-fibrogenic phenotype and Collagen-I expression. Recombinant OPN (rOPN) up-regulated Collagen-I protein in primary HSCs in a transforming growth factor beta (TGFβ)-independent fashion, whereas it down-regulated matrix metalloprotease-13 (MMP13), thus favoring scarring. rOPN activated primary HSCs, confirmed by increased α-smooth muscle actin (αSMA) expression and enhanced their invasive and wound-healing potential. HSCs isolated from wild-type (WT) mice were more profibrogenic than those from OPN knockout (Opn(-/-)) mice and infection of primary HSCs with an Ad-OPN increased Collagen-I, indicating correlation between both proteins. OPN induction of Collagen-I occurred via integrin α(v)β(3) engagement and activation of the phosphoinositide 3-kinase/phosphorylated Akt/nuclear factor kappa B (PI3K/pAkt/NFκB)-signaling pathway, whereas cluster of differentiation 44 (CD44) binding and mammalian target of rapamycin/70-kDa ribosomal protein S6 kinase (mTOR/p70S6K) were not involved. Neutralization of integrin α(v) β(3) prevented the OPN-mediated activation of the PI3K/pAkt/NFκB-signaling cascade and Collagen-I up-regulation. Likewise, inhibition of PI3K and NFκB blocked the OPN-mediated Collagen-I increase. Hepatitis C Virus (HCV) cirrhotic patients showed coinduction of Collagen-I and cleaved OPN compared to healthy individuals. Acute and chronic liver injury by CCl(4) injection or thioacetamide (TAA) treatment elevated OPN expression. Reactive oxygen species up-regulated OPN in vitro and in vivo and antioxidants prevented this effect. Transgenic mice overexpressing OPN in hepatocytes (Opn(HEP) Tg) mice developed spontaneous liver fibrosis compared to WT mice. Last, chronic CCl(4) injection and TAA treatment caused more liver fibrosis to WT than to Opn(-/-) mice and the reverse occurred in Opn(HEP) Tg mice.
CONCLUSION: OPN emerges as a key cytokine within the ECM protein network driving the increase in Collagen-I protein contributing to scarring and liver fibrosis.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21953216      PMCID: PMC3561739          DOI: 10.1002/hep.24701

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  37 in total

1.  Effect of oxymatrine on the p38 mitogen-activated protein kinases signalling pathway in rats with CCl4 induced hepatic fibrosis.

Authors:  Zi-Yu Deng; Jun Li; Yong Jin; Xiao-Liang Chen; Xiong-Wen Lü
Journal:  Chin Med J (Engl)       Date:  2009-06-20       Impact factor: 2.628

2.  The DNA binding protein BTEB mediates acetaldehyde-induced, jun N-terminal kinase-dependent alphaI(I) collagen gene expression in rat hepatic stellate cells.

Authors:  A Chen; B H Davis
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo.

Authors:  S De Minicis; C Candelaresi; M Marzioni; S Saccomano; T Roskams; A Casini; A Risaliti; R Salzano; N Cautero; F di Francesco; A Benedetti; G Svegliati-Baroni
Journal:  Gut       Date:  2007-11-07       Impact factor: 23.059

4.  Gene expression profiles during hepatic stellate cell activation in culture and in vivo.

Authors:  Samuele De Minicis; Ekihiro Seki; Hiroshi Uchinami; Johannes Kluwe; Yonghui Zhang; David A Brenner; Robert F Schwabe
Journal:  Gastroenterology       Date:  2007-02-21       Impact factor: 22.682

Review 5.  Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer.

Authors:  Shashi K Ramaiah; Susan Rittling
Journal:  Toxicol Sci       Date:  2007-09-22       Impact factor: 4.849

Review 6.  Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.

Authors:  Christian C Kazanecki; Dana J Uzwiak; David T Denhardt
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

7.  Characterization of anti-osteopontin monoclonal antibodies: Binding sensitivity to post-translational modifications.

Authors:  Christian C Kazanecki; Aaron J Kowalski; Tony Ding; Susan R Rittling; David T Denhardt
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

8.  Reactive oxygen species (ROS) mediate the effects of leucine on translation regulation and type I collagen production in hepatic stellate cells.

Authors:  María P Pérez de Obanos; María J López-Zabalza; Elena Arriazu; Teresa Modol; Jesús Prieto; María T Herraiz; María J Iraburu
Journal:  Biochim Biophys Acta       Date:  2007-07-24

9.  A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.

Authors:  Peter Fickert; Ulrike Stöger; Andrea Fuchsbichler; Tarek Moustafa; Hanns-Ulrich Marschall; Andreas H Weiglein; Oleksiy Tsybrovskyy; Hartmut Jaeschke; Kurt Zatloukal; Helmut Denk; Michael Trauner
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

10.  Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms.

Authors:  Francisco Javier Cubero; Natalia Nieto
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

View more
  92 in total

1.  Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation.

Authors:  Xiao Xiao; Yi Gang; Yong Gu; Lina Zhao; Jindong Chu; Jinfeng Zhou; Xiqiang Cai; Hui Zhang; Li Xu; Yongzhan Nie; Kaichun Wu; Zhiguo Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice.

Authors:  Hereward J Wimborne; Kenji Takemoto; Patrick M Woster; Don C Rockey; John J Lemasters; Zhi Zhong
Journal:  Free Radic Biol Med       Date:  2019-09-23       Impact factor: 7.376

3.  Angiotensin 1-7, but not the thrombin-cleaved osteopontin C-terminal fragment, attenuates osteopontin-mediated macrophage-induced endothelial-cell inflammation.

Authors:  Rachel Hamias; Assaf Rudich; George Greenberg; Gabriel Szendro; Talya Wolak
Journal:  Inflamm Res       Date:  2017-11-27       Impact factor: 4.575

4.  Innate and ozone-induced airway hyperresponsiveness in obese mice: role of TNF-α.

Authors:  Alison Suzanne Williams; Joel Andrew Mathews; David Itiro Kasahara; Allison Patricia Wurmbrand; Lucas Chen; Stephanie Ann Shore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-03       Impact factor: 5.464

5.  Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.

Authors:  Momoka Hayashida; Kei Hashimoto; Tomoko Ishikawa; Yasunori Miyamoto
Journal:  Int J Exp Pathol       Date:  2019-03-18       Impact factor: 1.925

6.  SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway.

Authors:  Zhipeng Du; Zhuoying Lin; Zhihui Wang; Danfei Liu; Dean Tian; Limin Xia
Journal:  Lab Invest       Date:  2020-04-14       Impact factor: 5.662

7.  The potential role of leptin in the vascular remodeling associated with obesity.

Authors:  E Martínez-Martínez; M Miana; R Jurado-López; M V Bartolomé; F V Souza Neto; M Salaices; N López-Andrés; V Cachofeiro
Journal:  Int J Obes (Lond)       Date:  2014-03-03       Impact factor: 5.095

Review 8.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

9.  Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice.

Authors:  Xiaodong Ge; Tung-Ming Leung; Elena Arriazu; Yongke Lu; Raquel Urtasun; Brian Christensen; Maria Isabel Fiel; Satoshi Mochida; Esben S Sørensen; Natalia Nieto
Journal:  Hepatology       Date:  2014-03-01       Impact factor: 17.425

Review 10.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.